Abstract

Tea polyphenolics have been suggested to possess blood glucose lowering properties by inhibiting sugar transporters in the small intestine and improving insulin sensitivity. In this report, we studied the effects of teas and tea catechins on the small intestinal sugar transporters, SGLT1 and GLUTs (GLUT1, 2 and 5). Green tea extract (GT), oolong tea extract (OT), and black tea extract (BT) inhibited glucose uptake into the intestinal Caco-2 cells with GT being the most potent inhibitor (IC50 : 0.077mg/mL), followed by OT (IC50 : 0.136mg/mL) and BT (IC50 : 0.56mg/mL). GT and OT inhibition of glucose uptake was partial non-competitive, with an inhibitor constant (Ki ) = 0.0317 and 0.0571mg/mL, respectively, whereas BT was pure non-competitive, Ki =0.36mg/mL. Oocytes injected to express small intestinal GLUTs were inhibited by teas, but SGLT1 was not. Furthermore, catechins present in teas were the predominant inhibitor of glucose uptake into Caco-2 cells, and gallated catechins the most potent: CG > ECG > EGCG≥GCG when compared to the non-gallated catechins (C, EC, GC, and EGC). In Caco-2 cells, individual tea catechins reduced the SGLT1 gene, but not protein expression levels. In contrast, GLUT2 gene and protein expression levels were reduced after 2hours exposure to catechins but increased after 24hours. These in vitro studies suggest teas containing catechins may be useful dietary supplements capable of blunting postprandial glycaemia in humans, including those with or at risk to Type 2 diabetes mellitus.

Highlights

  • Tea is produced from the buds and leaves of the plant Camellia sinensis (L.) O

  • We investigated the acute effects of green, oolong, and black tea extracts on reducing glucose uptake in human intestinal Caco-2 cells, a well-established in vitro model of the human enterocyte, which expresses many of the known intestinal sugar transporters, including SGLT1, GLUT1, GLUT2, GLUT3, and GLUT5.27-29 Xenopus oocytes, which express individual intestinal sugar transporters, were used to identify the transporters inhibited by the tea samples

  • We studied the effects of green, black, and oolong tea on intestinal sugar transport mediated by the Na+ dependent glucose transporter (SGLT1) and the facilitative sugar transporters, (GLUT1, 2 and 5)

Read more

Summary

| INTRODUCTION

Tea is produced from the buds and leaves of the plant Camellia sinensis (L.) O. According to different manufacturing processes, tea is generally classified into three types: non-fermented tea, partially fermented tea, and fully fermented tea.[1] Green tea is a non-fermented type and contains 20%-42% catechins (dry weight), which are flavonoid polyphenols that are considered to have number of potential health benefits, including a reduced risk of certain cancers, cardiovascular disease, and Type 2 diabetes mellitus (T2DM).[2] During black tea (fermented tea) manufacture, catechins in fresh leaves are oxidized into quinones by polyphenol oxidase and condensed to form theaflavins and thearubigins,[3] which results in a significant decrease of catechins (3%-10% of dry weight). We investigated the acute effects of green, oolong, and black tea extracts on reducing glucose uptake in human intestinal Caco-2 cells, a well-established in vitro model of the human enterocyte, which expresses many of the known intestinal sugar transporters, including SGLT1, GLUT1, GLUT2, GLUT3, and GLUT5.27-29 Xenopus oocytes, which express individual intestinal sugar transporters, were used to identify the transporters inhibited by the tea samples. In Caco-2 cells, we studied the short- and long-term effects of individual tea catechins on SGLT1 and GLUT2 gene and protein expression profiles

| MATERIALS AND METHODS
| Methods
| RESULTS
| DISCUSSION
Findings
CONFLICT OF INTEREST
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call